EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Conformational determinants of glucagon stability and aggregation kinetics in aqueous and commercial formulations

Angelo Santoro iD, Marco Macis, Michela Buonocore iD, Antonio Ricci iD, Anna Maria D'Ursi iD

Protein Science · 2026

DOI: 10.1002/pro.70750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, 2026. Verfasst von Angelo Santoro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Salerno, Italy. Hauptthemen laut MEDLINE: Glucagon. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon is a well‐established therapeutic peptide, widely used to treat hypoglycemia. Like many peptide drugs, it offers advantages such as specificity, biocompatibility, and high affinity for receptor targets, but suffers from limited physical and chemical stability. In particular, improper conditions can promote the formation of amyloid fibrils, leading to loss of biological activity and, in some cases, cytotoxicity. Understanding the conditions that modulate the structural behavior of glucagon is therefore crucial. Currently, two injectable formulations are available on the market: a lyophilized vial of glucagon with lactose at acidic pH, and a more recent auto‐injector ready‐to‐use (RTU) formulation containing glucagon in dimethyl sulfoxide (DMSO) with trehalose. In this study, we investigated the conformational properties of glucagon in these two marketed formulations and compared them with glucagon dissolved in aqueous solution at pH 3.5, a metastable condition prone to aggregation. Preliminary circular dichroism and fluorescence spectroscopy were used to confirm glucagon stability over time; subsequently, NMR analysis showed that structural destabilization consistently begins at the C‐terminal region, while the 11 Ser‐Leu 14 segment remains structured across all environments. These findings highlight two key determinants of glucagon stability and aggregation. Strategies that preserve the integrity of the C‐terminal region while stabilizing the 11 Ser‐Leu 14 motif may improve peptide solubility and extend shelf life, providing a rational basis for the design of next‐generation glucagon formulations for emergency use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucagonProtein AggregatesProtein StabilityKineticsProtein Conformation

Stichwörter der Autor:innen

conformational stabilityglucagonpeptide aggregationpeptide formulationstructure–stability relationship

Substanzen

GlucagonProtein Aggregates

Autor:innen und Institutionen

  • Department of Pharmacy, University of Salerno, Salerno, Italy.
  • Fresenius Kabi iPSUM, Rovigo, Italy.
  • Department of Chemical Sciences, University of Naples "Federico II," Complesso Universitario Monte Sant'Angelo, Naples, Italy.

ORCID-Profile: Angelo Santoro, Michela Buonocore, Antonio Ricci, Anna Maria D'Ursi

Zitieren

APA

Santoro, A., Macis, M., Buonocore, M., Ricci, A., & D'Ursi, A. M. (2026). Conformational determinants of glucagon stability and aggregation kinetics in aqueous and commercial formulations. Protein Science. https://doi.org/10.1002/pro.70750

Vancouver

Santoro A, Macis M, Buonocore M, Ricci A, D'Ursi AM. Conformational determinants of glucagon stability and aggregation kinetics in aqueous and commercial formulations. Protein Science. 2026. doi:10.1002/pro.70750

BibTeX
@article{Santoro2026,
  author = {Santoro, Angelo and Macis, Marco and Buonocore, Michela and Ricci, Antonio and D'Ursi, Anna Maria},
  title = {Conformational determinants of glucagon stability and aggregation kinetics in aqueous and commercial formulations},
  journal = {Protein Science},
  year = {2026},
  doi = {10.1002/pro.70750}
}
Kostenlos starten →